Colgate Q1 Review - Broadly In Line; Sales Revival Remains Elusive: Motilal Oswal

BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy..Motilal Oswal Report.Colgate-Palmolive India Ltd.’s Q1 FY23 sales and gross profit were in line. Higher than forecasted other expenses led to an Ebitda miss. The management said Q1 FY23 was impacted by a slowdown in rural India and inflationary pressures. It remains cautiously optimistic of improving trends in coming quarters. While we await the response of re-launches/launches and the strategy under the new Chief Executive Officer, the core issue of lack of sales growth (caused by high category penetration, especially when allied with the fact that Colgate has not shown any signs of regaining lost market share), will continue to delay rerating of the stock, given the little signs of a shift from its dependence on Oral Care..Click on the attachment to read the full report:.DISCLAIMERThis report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime..Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Colgate Q1 Review - Broadly In Line; Sales Revival Remains Elusive: Motilal Oswal

Colgate Q1 Review - Broadly In Line; Sales Revival Remains Elusive: Motilal Oswal

Choose a plan